Literature DB >> 31020578

Dynamic Restructuring of the Myocardial Mitochondria in Response to Uridine Modulation of the Activity of Mitochondrial ATP-Dependent Potassium Channel under Conditions of Acute Hypoxic Hypoxia.

G D Mironova1, E V Rozova2, N V Belosludtseva3, I N Man'kovskaya2.   

Abstract

We studied the effects of in vivo modulation of activity of mitochondrial ATP-dependent potassium channel (mitoKATP) by uridine on the morphofunctional state of mitochondria in rat cardiomyocytes under conditions of acute hypoxia. Preinjection of uridine to animals reduced the number of structurally modified mitochondria, but had practically no effect on their morphogenesis after hypoxia. Uridine in vivo stimulated the formation of micromitochondria and their release into the cytoplasm. The number of "maternal" mitochondria containing three and more new micromitochondria, increased as well. The use of mitoKATP blocker 5-hydroxydecanoate in parallel with uridine abolished its protective effect, as it significantly inhibited the formation of micromitochondria in rat cardiomyocytes after acute hypoxic exposure.

Entities:  

Keywords:  5-hydroxydecanoate; acute hypoxic hypoxia; mitochondrial ATP-dependent potassium channel; myocardium; uridine

Mesh:

Substances:

Year:  2019        PMID: 31020578     DOI: 10.1007/s10517-019-04445-9

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  2 in total

1.  Does the Operation of Mitochondrial ATP-Dependent Potassium Channels Affect the Structural Component of Mitochondrial and Endothelial Dysfunctions in Experimental Parkinsonism?

Authors:  A A Mosentsov; E V Rozova; N V Belosludtseva; I N Mankovskaya; Yu V Putiy; I N Karaban; I B Mikheeva; G D Mironova
Journal:  Bull Exp Biol Med       Date:  2021-03-16       Impact factor: 0.804

2.  Mitochondrial proteomics alterations in rat hearts following ischemia/reperfusion and diazoxide post‑conditioning.

Authors:  Yunchao Pan; Yuan Wang; Wenyan Shi; Yun Liu; Song Cao; Tian Yu
Journal:  Mol Med Rep       Date:  2020-12-23       Impact factor: 2.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.